10x from here28 Mar 2026 11:50
As of March 28, 2026, the US-Iran conflict has fundamentally rewired the specialty chemical industry. While global markets are volatile, Synthomer (SYNT.L) has emerged as a high-leverage "fortress" play due to its unique insulation from Middle Eastern supply shocks.
Investment Summary Market Price Impact from Conflict: Product prices are currently "rocketing." With the Strait of Hormuz effectively closed, global supply of specialty chemicals has cratered. Major peers like Lanxess and BASF have already announced price hikes of 30% to 50% to cover energy and feedstock scarcity.
Sourcing Moat / Mandatory Pass-Through: Synthomer operates a "Regional Sourcing" model, with ~72% of its feedstock/production located in the US and Europe. While Asian rivals are declaring force majeure due to naphtha shortages, Synthomer is fully operational. Crucially, as of their March 19, 2026 update, they are implementing 100% mandatory price adjustments, passing all raw material and energy surcharges directly to customers.
Product Demand: Shortages in Asia and the Middle East have triggered a "panic-switch" among industrial buyers. Customers in the coatings, adhesives, and medical sectors are flocking to Synthomer to guarantee supply security, shifting market share away from conflict-hit regions. Valuation Gap: The disparity is extreme. While North American peers like AdvanSix (ASIX) trade at a 0.69 P/B, Synthomer sits at a microscopic 0.04 P/B. The market cap is only £50 Million ($62.5M USD), yet the company generates $2.17 Billion (£1.74B) in revenue. Potential Upside: With the Board officially ruling out an equity raise in mid-March and debt refinancing progressing constructively, the "bankruptcy risk" is evaporating. If SYNT.L re-rates even to a conservative 0.40 P/B (matching Lanxess), it represents a 1,000% (10x) return from current levels.